Beyond size: A comprehensive overview of small-volume benign prostatic hyperplasia

Abstract

Benign prostatic hyperplasia (BPH) is one of the most frequently diagnosed benign disorders that cause dysuria in middle-aged and elderly men. Some patients with BPH have relatively small prostates (referred to as small-volume BPH) but still experience the lower urinary tract infection. Medication treatment is typically not successful in these patients. In addition, their pathophysiologic pathways deviate from those previously observed. Furthermore, as there is no accepted protocol for the diagnosis and treatment of small-volume BPH, patients can experience great difficulties in managing surgical complications such as bladder neck contracture. Thus, we reviewed the features of small-volume prostates, preoperative assessment, surgical technique, and management of complications.

Keywords

Small-volume prostate / Benign prostatic hyperplasia / Surgical treatment / Bladder neck contracture

Acknowledgments

None.

Statement of ethics

Not applicable.

Conflict of interest statement

SX is the Editor-in-Chief of Current Urology, BH is an Editorial Board member of Current Urology. The other authors declare no conflicts of interest.

Funding source

This study was supported by the National Nature Science Foundation of China (No. 82270810).

Author contributions

JX: Manuscript writing;

BH, SX, YJ: Manuscript editing and guidance on writing.

Data availability

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

References

[1] Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. J Urol 1984; 132(3):474-479.

[2] GBD 2021 Demographics Collaborators. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: A comprehensive demographic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403(10440):1989-2056.

[3] Sandhu JS, Bixler BR, Dahm P, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol 2024; 211(1):11-19.

[4] Massanova M, Robertson S, Barone B, et al. The comparison of imaging and clinical methods to estimate prostate volume: A single-centre retrospective study. Urol Int 2021; 105(9-10):804-810.

[5] Aho TF, Gilling PJ, Kennett KM, Westenberg AM, Fraundorfer MR, Frampton CM. Holmium laser bladder neck incision versus holmium enucleation of the prostate as outpatient procedures for prostates less than 40 grams: A randomized trial. J Urol 2005; 174(1):210-214.

[6] Kim KS, Lee SH, Cho HJ, Suh HJ, Lee DH, Choi YS. Comparison of bipolar plasma vaporization versus standard holmium laser enucleation of the prostate: Surgical procedures and clinical outcomes for small prostate volumes. J Clin Med 2019; 8(7):1007.

[7] Gravas S, Gacci M, Gratzke C, et al. Summary paper on the 2023 European Association of Urology guidelines on the management of non-neurogenic male lower urinary tract symptoms. Eur Urol 2023; 84(2):207-222.

[8] Roehrborn CG. Pathology of benign prostatic hyperplasia. Int J Impot Res 2008; 20(Suppl 3):S11-S18.

[9] Yang Y, Wu SL, Duan JH, et al. The relationship between the weight of prostate and the degree of bladder outlet obstruction. Chin J Urol 1999; 20(1):44246.

[10] Li X, Pan JH, Liu QG, et al. Selective transurethral resection of the prostate combined with transurethral incision of the bladder neck for bladder outlet obstruction in patients with small volume benign prostate hyperplasia (BPH): A prospective randomized study. PLoS One 2013; 8(5):e63227.

[11] Wang C, Li P, Zhang Q, et al. The effect of holmium laser enucleation of the prostate in the treatment of small volume benign prostate hyperplasia. Chin J Urol 2021; 42(11):839-843.

[12] Ku JH, Ko DW, Cho JY, Oh SJ. Correlation between prostatic urethral angle and bladder outlet obstruction index in patients with lower urinary tract symptoms. Urology 2010; 75(6):1467-1471.

[13] Park YJ, Bae KH, Jin BS, Jung HJ, Park JS. Is increased prostatic urethral angle related to lower urinary tract symptoms in males with benign prostatic hyperplasia/lower urinary tract symptoms? Korean J Urol 2012; 53(6):410-413.

[14] Cao T, Xie F, Shi Y, et al. Rapamycin and low-dose IL-2 mediate an immunosuppressive microenvironment to inhibit benign prostatic hyperplasia. Int J Biol Sci 2023; 19(11):3441-3455.

[15] Biardeau X, Elkoushy MA, Aharony S, Elhilali M, Corcos J. Is multichannel urodynamic assessment necessary before considering a surgical treatment of BPH? Pros and cons. World J Urol 2016; 34(4):463-469.

[16] Boormans JL, Boon TA. Invasively estimated international continence society obstruction classification versus noninvasively assessed bladder outlet obstruction probability in treatment recommendation for LUTS suggestive of BPH. Urology 2007; 69(3):485-490.

[17] Klingler HC, Madersbacher S, Djavan B, Schatzl G, Marberger M, Schmidbauer CP. Morbidity of the evaluation of the lower urinary tract with transurethral multichannel pressure-flow studies. J Urol 1998; 159(1):191-194.

[18] Gomes CM, Nunes RV, Araújo RM, et al. Urodynamic evaluation of patients with lower urinary tract symptoms and small prostate volume. Urol Int 2008; 81(2):129-134.

[19] Drake MJ, Lewis AL, Young GJ, et al. Diagnostic assessment of lower urinary tract symptoms in men considering prostate surgery: A noninferiority randomised controlled trial of urodynamics in 26 hospitals. Eur Urol 2020; 78(5):701-710.

[20] Fogaing C, Alsulihem A, Campeau L, Corcos J. Is early surgical treatment for benign prostatic hyperplasia preferable to prolonged medical therapy: Pros and cons. Medicina (Kaunas) 2021; 57(4):368.

[21] Park S, Kwon T, Park S, Moon KH. Efficacy of holmium laser enucleation of the prostate in patients with a small prostate (≤30 mL). World J Mens Health 2017; 35(3):163-169.

[22] Hashimoto M, Shimizu N, Sugimoto K, et al. Efficacy of adding dutasteride to α-blocker therapy treated benign prostatic hyperplasia patients with small volume prostate (<30 mL). Low Urin Tract Symptoms 2017; 9(3):157-160.

[23] Kang M, Kim M, Choo MS, Paick JS, Oh SJ. Urodynamic features and significant predictors of bladder outlet obstruction in patients with lower urinary tract symptoms/benign prostatic hyperplasia and small prostate volume. Urology 2016;89:96-102.

[24] Thomas AW, Cannon A, Bartlett E, Ellis-Jones J, Abrams P. The natural history of lower urinary tract dysfunction in men: Minimum 10-year urodynamic followup of transurethral resection of prostate for bladder outlet obstruction. J Urol 2005; 174(5):1887-1891.

[25] Pandolfo SD, Crauso F, Aveta A, et al. A novel low-cost uroflowmetry for patient telemonitoring. Int J Environ Res Public Health 2023; 20(4):3287.

[26] Orandi A. Transurethral incision of the prostate. J Urol 1973; 110(2):229-231.

[27] Yang Q, Peters TJ, Donovan JL, Wilt TJ, Abrams P. Transurethral incision compared with transurethral resection of the prostate for bladder outlet obstruction: A systematic review and meta-analysis of randomized controlled trials. J Urol 2001; 165(5):1526-1532.

[28] Lourenco T, Shaw M, Fraser C, MacLennan G, N'Dow J, Pickard R. The clinical effectiveness of transurethral incision of the prostate: A systematic review of randomised controlled trials. World J Urol 2010; 28(1):23-32.

[29] He W, Ding T, Niu Z, et al. Reoperation after surgical treatment for benign prostatic hyperplasia: A systematic review. Front Endocrinol (Lausanne) 2023;14:1287212.

[30] Mulvaney WP, Beck CW. The laser beam in urology. J Urol 1968; 99(1):112-115.

[31] Huang SW, Tsai CY, Tseng CS, et al. Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: Systematic review and network meta-analysis. BMJ 2019;367:l5919.

[32] Rieken M, Bachmann A. Laser treatment of benign prostate enlargement—which laser for which prostate? Nat Rev Urol 2014; 11(3):142-152.

[33] Bach T, Xia SJ, Yang Y, et al. Thulium:YAG 2 mum cw laser prostatectomy: Where do we stand? World J Urol 2010; 28(2):163-168.

[34] Vargas C, García-Larrosa A, Capdevila S, Laborda A. Vaporization of the prostate with 150-W thulium laser: Complications with 6-month follow-up. J Endourol 2014; 28(7):841-845.

[35] Sun Q, Guo W, Cui D, et al. Thulium laser enucleation versus thulium laser resection of the prostate for prevention of bladder neck contracture in a small prostate: A prospective randomized trial. World J Urol 2019; 37(5):853-859.

[36] Primiceri G, Castellan P, Marchioni M, Schips L, Cindolo L. Bladder neck contracture after endoscopic surgery for benign prostatic obstruction: Incidence, treatment, and outcomes. Curr Urol Rep 2017; 18(10):79.

[37] Kumar A, Vasudeva P, Kumar N, Nanda B, Jha SK, Mohanty N. A prospective randomized comparative study of monopolar and bipolar transurethral resection of the prostate and photoselective vaporization of the prostate in patients who present with benign prostatic obstruction: A single center experience. J Endourol 2013; 27(10):1245-1253.

[38] Al-Ansari A, Younes N, Sampige VP, et al. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: A randomized clinical trial with midterm follow-up. Eur Urol 2010; 58(3):349-355.

[39] Pandolfo SD, Del Giudice F, Chung BI, et al. Robotic assisted simple prostatectomy versus other treatment modalities for large benign prostatic hyperplasia: A systematic review and meta-analysis of over 6500 cases. Prostate Cancer Prostatic Dis 2023; 26(3):495-510.

[40] Herrmann TRW. Endoscopic enucleation of the prostate is better than robot-assisted simple prostatectomy. Eur Urol Focus 2022; 8(2):365-367.

[41] Autorino R, Amparore D, Loizzo D, Pandolfo SD, Checcucci E, Porpiglia F. Robot-assisted simple prostatectomy is better than endoscopic enucleation of the prostate. Eur Urol Focus 2022; 8(2):368-370.

[42] Nguyen DD, Li T, Ferreira R, et al. Ablative minimally invasive surgical therapies for benign prostatic hyperplasia: A review of Aquablation, Rezum, and transperineal laser prostate ablation. Prostate Cancer Prostatic Dis 2024; 27(1):22-28.

[43] Franco JVA, Jung JH, Imamura M, et al. Minimally invasive treatments for benign prostatic hyperplasia: A Cochrane network meta-analysis. BJU Int 2022; 130(2):142-156.

[44] McVary KT, Gittelman MC, Goldberg KA, et al. Final 5-year outcomes of the multicenter randomized sham-controlled trial of a water vapor thermal therapy for treatment of moderate to severe lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2021; 206(3):715-724.

[45] Lerner LB, McVary KT, Barry MJ, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia: AUA GUIDELINE PART I—initial work-up and medical management. J Urol 2021; 206(4):806-817.

[46] Ines M, Babar M, Singh S, Iqbal N, Ciatto M. Real-world evidence with the Rezūm system: A retrospective study and comparative analysis on the efficacy and safety of 12 month outcomes across a broad range of prostate volumes. Prostate 2021; 81(13):956-970.

[47] Long JD, Smith SR; Members of the Cochrane Nursing Care (CN). Prostatic urethral lift for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia: A Cochrane review summary. Int J Nurs Stud 2021;115:103492.

[48] Perera M, Roberts MJ, Doi SA, Bolton D. Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: A systematic review and meta-analysis. Eur Urol 2015; 67(4):704-713.

[49] Cantwell AL, Bogache WK, Richardson SF, et al. Multicentre prospective crossover study of the ‘prostatic urethral lift’ for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia. BJU Int 2014; 113(4):615-622.

[50] Garcia C, Chin P, Rashid P, Woo HH. Prostatic urethral lift: A minimally invasive treatment for benign prostatic hyperplasia. Prostate Int 2015; 3(1):1-5.

[51] Ditonno F, Manfredi C, Licari LC, et al. Benign prostatic hyperplasia surgery: A snapshot of trends, costs, and surgical retreatment rates in the USA. Eur Urol Focus 2024;S2405-4569(24)00058-0.

[52] Morton A, Williams M, Perera M, et al. Management of benign prostatic hyperplasia in the 21st century: Temporal trends in Australian population-based data. BJU Int 2020; 126(Suppl 1):18-26.

[53] Trama F, Lauro GD, Illiano E, et al. Ejaculation sparing thulium laser enucleation of the prostate: An observational prospective study. J Clin Med 2022; 11(21):6365.

[54] Cornu JN, Ahyai S, Bachmann A, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: An update. Eur Urol 2015; 67(6):1066-1096.

[55] Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)—incidence, management, and prevention. Eur Urol 2006; 50(5):969-979; discussion 980.

[56] Lee YH, Chiu AW, Huang JK. Comprehensive study of bladder neck contracture after transurethral resection of prostate. Urology 2005; 65(3):498-503; discussion 503.

[57] Elkoushy MA, Elshal AM, Elhilali MM. Reoperation after holmium laser enucleation of the prostate for management of benign prostatic hyperplasia: Assessment of risk factors with time to event analysis. J Endourol 2015; 29(7):797-804.

[58] Grechenkov A, Sukhanov R, Bezrukov E, et al. Risk factors for urethral stricture and/or bladder neck contracture after monopolar transurethral resection of the prostate for benign prostatic hyperplasia. Urologia 2018; 85(4):150-157.

[59] Jaeger CD, Mitchell CR, Mynderse LA, Krambeck AE. Holmium laser enucleation (HoLEP) and photoselective vaporisation of the prostate (PVP) for patients with benign prostatic hyperplasia (BPH) and chronic urinary retention. BJU Int 2015; 115(2):295-299.

[60] Chen YH, Li XD, Ke ZB, et al. Risk factors for the postoperative bladder neck contracture in patients with small-volume prostatic hyperplasia. Asian J Surg 2023; 46(1):373-379.

[61] Zhang L, Liu S, Wu K, Mu X, Yang L. Management of highly recurrent bladder neck contractures via transurethral resection combined with intra- and post-operative triamcinolone acetonide injections. World J Urol 2021; 39(2):527-532.

[62] Branche B, Crocerossa F, Carbonara U, et al. Management of bladder neck contracture in the age of robotic prostatectomy: An evidence-based guide. Eur Urol Focus 2022; 8(1):297-301.

[63] Vanni AJ, Zinman LN, Buckley JC. Radial urethrotomy and intralesional mitomycin C for the management of recurrent bladder neck contractures. J Urol 2011; 186(1):156-160.

[64] Redshaw JD, Broghammer JA, Smith TG 3rd, et al. Intralesional injection of mitomycin C at transurethral incision of bladder neck contracture may offer limited benefit: TURNS study group. J Urol 2015; 193(2):587-592.

[65] Eltahawy E, Gur U, Virasoro R, Schlossberg SM, Jordan GH. Management of recurrent anastomotic stenosis following radical prostatectomy using holmium laser and steroid injection. BJU Int 2008; 102(7):796-798.